Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses

By sjmartinez • March 21, 2024

Yuen MF, Fung S, Ma X, Nguyen TT, Hassanein T, Hann HW, Elkhashab M, Nahass RG, Park JS, Jacobson IM, Ayoub WS, Han SH, Gane EJ, Zomorodi K, Yan R, Ma J, Knox SJ, Stamm LM, Bonacini M, Weilert F, Ramji A, Bennett M, Ravendhran N, Chan S, Dieterich DT, Kwo PY, Schiff ER, Bae HS, Lalezari J, Agarwal K, Sulkowski MS. Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses. JHEP Rep. 2024 Jan 18;6(4):100999. doi: 10.1016/j.jhepr.2023.100999. PMID: 38510983; PMCID: PMC10951643.

Tags: Antiviral, Cedars Sinai DoM, Core inhibitor, Digestive Diseases, Hepatitis, hepatitis B virus, Nucleos(t)ide reverse transcriptase inhibitor, Off-treatment, Open-label, Publications, Viral relapse

Improved Assessment of Coronary Artery Disease in Obese Subjects with Flurpiridaz-18F PET Myocardial Perfusion Imaging: A Prespecified Subgroup Analysis of the AURORA Phase 3 Study

Patel KK, Maddahi J, Agostini D, Bax JJ, Beanlands RSB, Berman D, Dorbala S, Heller GV, Knuuti JM, Pelletier-Galarneau M, Tamaki N, Thompson D, Somer[...]

30-Day Outcomes of a Single-Stage Transfemoral Mitral Valve Replacement System in Severe Mitral Valve Disease

Yadav PK, Vahl TP, Thourani VH, Latib A, Chehab BM, Rinaldi M, Makkar R, Rogers JH, Rodés-Cabau J, Singh G, Gössl M, Sorajja P, Reardon[...]

Single-cell and spatial omics in liver identify cell-cell communication regulators in aging and insulin resistance

Zhao W, Jiao X, Du K, Sun Q, Duan J, Cao Y, Shen X, Said Z, Karri SS, Ellsworth P, Hu W, Sargsyan A, Astapova[...]